ARCHIVES

Adding Velcade Increased Overall Survival By 13.3 Months at Five-Year Analysis

This article is from The Cancer Letter archive.

Vol. 34 No. 12 | December 30, 2011

Download PDF Visit The Full Archive

Related Articles

Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer

June 27, 2014

In Brief: Kenneth Olden Named Director Of Howard Cancer Center; Calhoon Sparked AMA On Cigarette Ads

February 21, 1986

J&J, Amgen Settle Lawsuit Over ESAs As FDA Prepares Another Label Change.

July 18, 2008

Immunotherapy Demonstrates Disease Control in Phase II Study

September 28, 2012

MacFarlane, Frelick to Speak At Seminar

July 22, 1983

Nurses’ Work Environment Needs Change To Protect Patients From Errors, IOM Says

November 28, 2003